Skip to main navigation
Sangamo Therapeutics, Inc
  • About Us
    • Leadership
    • Locations
    • Contact
  • Technology
    • Genomic Medicines
      • Gene Therapy
      • Cell Therapy
      • Genome Editing
      • Genome Regulation
    • Zinc Finger Platform
    • Presentations
    • Publications
  • Pipeline
  • Patients
    • Patient Stories
      • Stories of MPS
      • Stories of Hemophilia
      • Stories of Fabry Disease
      • Stories of Stories of Beta Thalassemia
    • Resources
    • Expanded Access Program
  • Clinical Trials
  • Collaborations
  • Investors + Media
    • Investors + Media
      • Corporate Profile
      • Email Alerts
      • Media Library
    • Stock Information
      • Historic Price Lookup
      • Investment Calculator
      • Institutional Ownership
    • News Releases
    • Events + Presentations
    • Financials + SEC Filings
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
      • Financial Fundamentals
        • Trading Statistics
        • Balance Sheet
        • Income Statement
        • Cash Flow
        • Snapshot
    • Corporate Governance
      • Leadership
      • Committee Composition
  • Careers
    • Sangamo Culture
    • Our Values
    • Job Opportunities
  • About Us
    • Leadership
    • Locations
    • Contact
  • Technology
    • Genomic Medicines
      • Gene Therapy
      • Cell Therapy
      • Genome Editing
      • Genome Regulation
    • Zinc Finger Platform
    • Presentations
    • Publications
  • Pipeline
  • Patients
    • Patient Stories
      • Stories of MPS
      • Stories of Hemophilia
      • Stories of Fabry Disease
      • Stories of Stories of Beta Thalassemia
    • Resources
    • Expanded Access Program
  • Clinical Trials
  • Collaborations
  • Investors + Media
    • Investors + Media
      • Corporate Profile
      • Email Alerts
      • Media Library
    • Stock Information
      • Historic Price Lookup
      • Investment Calculator
      • Institutional Ownership
    • News Releases
    • Events + Presentations
    • Financials + SEC Filings
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
      • Financial Fundamentals
        • Trading Statistics
        • Balance Sheet
        • Income Statement
        • Cash Flow
        • Snapshot
    • Corporate Governance
      • Leadership
      • Committee Composition
  • Careers
    • Sangamo Culture
    • Our Values
    • Job Opportunities

Governance Documents

  • Investors + Media
    • Corporate Profile
    • Email Alerts
    • Media Library
  • Stock Information
    • Historic Price Lookup
    • Investment Calculator
    • Institutional Ownership
  • News Releases
  • Events + Presentations
  • Financials + SEC Filings
    • Quarterly Results
    • Analyst Coverage
    • Earnings Estimates
    • Financial Fundamentals
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Snapshot
  • Corporate Governance
    • Leadership Team
    • Board of Directors
    • Committee Composition

Governance Documents

Governance Documents

  • Code of Business Conduct and Ethics

    Code of Business Conduct and Ethics 96.8 KB

Committee Charters

  • Nominating & Corporate Governance Committee Charter

    July 22, 2020
    Nominating & Corporate Governance Committee Charter 186.6 KB
  • Audit Committee Charter

    Audit Committee Charter 91.2 KB
  • Compensation Committee Charter

    Compensation Committee Charter 96.2 KB
footer-logo

© Sangamo Therapeutics

LinkedIn Twitter Facebook
  • Disclaimer
  • Privacy Policy